Reference is made to the subsequent offering in IDEX Biometrics ASA (the "Company”) approved by the Extraordinary General Meeting on 9 October 2024.
The Company's CEO, Catharina Eklof, holds 380,880 subscription rights in the subsequent offering. Eklof has fully subscribed based on these subscription rights and, further, has oversubscribed, resulting in a total subscription of 1,000,000 shares, at NOK 0.15 per share.
The final allocation will be notified after the subscription period in the subsequent offering ends on 29 November 2024 at 16:30 CET, including the primary insider registration form. Eklof currently holds 694,403 shares in IDEX Biometrics ASA.
For further information contact:
Marianne Bøe, Head of Investor Relations
Kristian Flaten, CFO
E-mail: [email protected]
Tel: + 47 67 83 91 19
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This notice was issued by Marianne Bøe, Head of Investor Relations, on 28 November 2024 at 08:30 CET on behalf of IDEX Biometrics ASA.
